Hangzhou Aiweike Biotechnology
Latest round
- Series A
Last raised
- May 2022
Total raised
- Undisclosed
Investors
- 5
About Hangzhou Aiweike Biotechnology
Established in 2022 and based in Hangzhou, China, Hangzhou Aiweike Biotechnology is a manufacturer of biological products, focusing on bio-based materials technology research and development, biomass energy technology services, and bio-chemical products technology research and development. The company mainly develops and produces early tumor screening products, and also includes the development of bio-based material technology and the production of Class II medical devices.
Who invested in Hangzhou Aiweike Biotechnology
5 investors across 1 round
See all investors in Hangzhou Aiweike Biotechnology
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
May 1, 2022
Amount
Undisclosed
Investors
Questions about Hangzhou Aiweike Biotechnology
Who invested in Hangzhou Aiweike Biotechnology?
Hangzhou Aiweike Biotechnology has 5 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Hangzhou Aiweike Biotechnology raised?
Hangzhou Aiweike Biotechnology has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Hangzhou Aiweike Biotechnology last raise money?
Hangzhou Aiweike Biotechnology's most recent round on record is a Series A, in May 2022.
What does Hangzhou Aiweike Biotechnology do?
Established in 2022 and based in Hangzhou, China, Hangzhou Aiweike Biotechnology is a manufacturer of biological products, focusing on bio-based materials technology research and development, biomass energy technology services, and bio-chemical products technology research and development.
Where is Hangzhou Aiweike Biotechnology headquartered?
Hangzhou Aiweike Biotechnology is headquartered in Hangzhou, China.
Which VCs invest in companies like Hangzhou Aiweike Biotechnology?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Hangzhou Aiweike Biotechnology's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Hangzhou Aiweike Biotechnology? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.